We specialize in tri-state healthcare M&A. Article 28 D&TCs, Article 31 / MHOTRS clinics, ambulatory surgery centers, dialysis, imaging, and FQHC affiliations. Get a free confidential valuation in 14 days. No obligation, no follow-up if there's no fit.
Our buy-side mandate currently includes a healthcare-experienced acquirer with $5M–$15M+ EV actively in market through 2026 and 2027. Your timing may be perfect.
Direct: 201-400-9827 • steven@nexusbridgebrokers.com
Healthcare M&A is a specialty. Generic business brokers leave money on the table on every deal.
We close NY Article 28 and Article 31 transactions. We know PHHPC, OMH, NJ DOH, CT DPH. Our deal team includes healthcare-specialist counsel, QofE accountants, and regulatory consultants.
We currently represent a healthcare-experienced buyer with a $5M–$15M+ enterprise value mandate. If your practice fits, you may have a buyer at the table within 60 days.
Article 28 D&TCs: 7–9x EBITDA. ASCs: 8–11x. Behavioral health: 8–12x. We push for the upper end of the band — and have escalator fees that align our economics with yours.
From first conversation to signed engagement letter — typically 2 weeks. From listing to close — typically 9–14 months.
14-day turnaround. We review your last 3 years of P&Ls and provide a market range.
Mutual NDA. We sign a sell-side advisory engagement and prepare your CIM and data room.
Targeted outreach to qualified buyers + co-broker network. NDAs signed before any seller info shared.
Negotiate LOI. Manage diligence + PHHPC/OMH approvals. Close at the highest defensible price.
From listing to close, typically 9–14 months for Article 28 (PHHPC Certificate of Need is the long pole — 4–9 months). Article 31 / MHOTRS clinics close faster — typically 6–10 months — because OMH license transfer is quicker than PHHPC.
Article 28 D&TCs: 7–9x EBITDA. ASC platforms: 8–11x. Behavioral health platforms: 8–12x. Imaging: 6–8x. Dialysis: 7–10x. Multiples expand for in-network managed-care contracts, multi-site footprint, owner transition agreements, and clean compliance histories.
Yes — equity rollover is common in healthcare M&A. Rolling 20–40% of your sale proceeds into the buyer's MSO is standard, and gives you continued upside if the buyer grows the platform.
Generally not. We run confidential processes under NDA. Buyers sign NDAs before receiving any identifying information. Staff and patients are notified only after the regulatory transition is finalized — typically 2–4 weeks before close.
For sell-side healthcare practice listings: $0 upfront retainer, success fee 8–10% on a sliding scale based on transaction size. Co-broker friendly (50/50 standard split). For larger transactions, we offer escalator fees that increase our commission above a target sale price — aligning our economics with yours.
Start preparing now. The single biggest determinant of sale price is the quality of your operations and financials in the 24 months before going to market. We provide free 24-month preparation roadmaps to owner-operators considering a future exit.
Yes — we coordinate real estate sales with practice sales. Most buyers prefer to acquire the practice and either purchase the real estate at closing or enter a long-term lease. We can structure either path.